SCHEMBL3759906

SCHEMBL3759906

Oc1ccc(C23CC4CC(c5ccc(O)cc5O)(C2)CC(c2ccc(O)cc2O)(C4)C3)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
ALOX5AP P20292 1/20 0.36
HSP90AA1 P07900 1/20 0.34
TYR P14679 1/20 0.33
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
RARB P10826 1/20 0.33
CES2 O00748 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
NR3C1 P04150 1/20 0.32
NR2E1 Q9Y466 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3843069 0.93 CNR2 (0.35) CNR2MEN1KMT2APOLBGAA
SCHEMBL3842486 0.90 CNR2 (0.34) CNR2MEN1KMT2APOLBGAA
SCHEMBL2426368 0.89 KMT2A (0.43) CNR2MEN1KMT2APOLBGAA
SCHEMBL3846906 0.87 MEN1 (0.41) CNR2MEN1KMT2APOLBGAA
SCHEMBL3849641 0.86 CNR2 (0.37) CNR2MEN1KMT2APOLBGAA
SCHEMBL3759822 0.86 TYR (0.39) TYRLMNAALOX12CES2ESR1
SCHEMBL3764016 0.85 ALOX5AP (0.45) CNR2MEN1KMT2APOLBGAA
SCHEMBL2420330 0.85 MEN1 (0.50) CNR2MEN1KMT2APOLBGAA
SCHEMBL3845041 0.81 KMT2A (0.40) CNR2MEN1KMT2APOLBGAA
SCHEMBL14040564 0.81 CNR2 (0.43) CNR2MEN1KMT2APOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084650-B2 Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those IDEMITSU KOSAN CO., LTD. (JP) 2011-12-27 US disclosed
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE IDEMITSU KOSAN CO., LTD. (JP) 2010-11-25 US disclosed
EP-1985616-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE Idemitsu Kosan Co., Ltd. (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE AOC1, ASIC1, ICAM1 CNR2 3558/4885MEN1 2523/4885KMT2A 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.